Greif Closes $57M Envaplast Buy, Guides FY26 EBITDA to $615M–$635M
GEF sits 55% above its 52-week low of $55.75.
Summary
Greif closed the $57M acquisition of Envaplast, adding small-polymer container capacity in Spain for agrochemical and pharma markets. The deal met margin and cash-flow targets, and shares rose ~3%. Management also guided FY2026 adjusted EBITDA to $615M–$635M and adjusted free cash flow to $305M–$325M, citing subdued industrial demand from geopolitical uncertainty. This follows the strong Q3 report and raised guidance from last week, reinforcing the positive trajectory. The Envaplast buy expands Greif's footprint in higher-value end markets, complementing recent price increases and cost actions.
At the time of this announcement, GEF was trading at $86.55 on NYSE in the Manufacturing sector, with a market capitalization of approximately $4.5B. The 52-week trading range was $55.75 to $88.50. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Wiseek News.